JP2011512134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011512134A5 JP2011512134A5 JP2010546400A JP2010546400A JP2011512134A5 JP 2011512134 A5 JP2011512134 A5 JP 2011512134A5 JP 2010546400 A JP2010546400 A JP 2010546400A JP 2010546400 A JP2010546400 A JP 2010546400A JP 2011512134 A5 JP2011512134 A5 JP 2011512134A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide linker
- motif
- polypeptides
- modified
- fusion polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0802978A GB0802978D0 (en) | 2008-02-19 | 2008-02-19 | Modified linkers |
| GB0821076A GB0821076D0 (en) | 2008-11-19 | 2008-11-19 | Modified linkers |
| GB0900539A GB0900539D0 (en) | 2009-01-14 | 2009-01-14 | Modified linkers |
| PCT/GB2009/000437 WO2009103965A1 (en) | 2008-02-19 | 2009-02-18 | Modified linkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011512134A JP2011512134A (ja) | 2011-04-21 |
| JP2011512134A5 true JP2011512134A5 (enExample) | 2012-04-12 |
Family
ID=40845701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010546400A Withdrawn JP2011512134A (ja) | 2008-02-19 | 2009-02-18 | 修飾リンカー |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110172165A1 (enExample) |
| EP (1) | EP2288386A1 (enExample) |
| JP (1) | JP2011512134A (enExample) |
| WO (1) | WO2009103965A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0719818D0 (en) * | 2007-10-11 | 2007-11-21 | Asterion Ltd | Growth hormone fusion polypeptides |
| JP2012520073A (ja) * | 2009-03-10 | 2012-09-06 | ベイラー リサーチ インスティテュート | 抗原提示細胞ターゲティングワクチン |
| US8734774B2 (en) | 2010-04-02 | 2014-05-27 | University Of Rochester | Protease activated cytokines |
| IN2014CN02399A (enExample) | 2011-09-04 | 2015-06-19 | Glytech Inc | |
| SG11201400293UA (en) * | 2011-09-04 | 2014-08-28 | Glytech Inc | Glycosylated polypeptide and drug composition containing said polypeptide |
| EP2732824A1 (en) * | 2012-11-16 | 2014-05-21 | Ceva Sante Animale | Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone |
| EP3068891A1 (en) * | 2013-11-13 | 2016-09-21 | Aequus Biopharma Inc. | Engineered glycoproteins and uses thereof |
| JP2018518955A (ja) * | 2015-06-11 | 2018-07-19 | ジェネクシン・インコーポレイテッドGenexine, Inc. | 改変されたインターロイキン−7タンパク質およびその使用 |
| CA3084262A1 (en) * | 2017-12-06 | 2019-06-13 | The Board Of Trustees Of The Leland Stanford Junior University | Engineered proteins to enhance sensitivity of a cell to il-2 |
| CN113840832A (zh) | 2018-05-14 | 2021-12-24 | 狼人治疗公司 | 可活化白介素-2多肽及其使用方法 |
| MX2020012252A (es) | 2018-05-14 | 2021-04-28 | Werewolf Therapeutics Inc | Polipeptidos de interleucina 12 activables y metodos de uso de los mismos. |
| EP3969035A4 (en) | 2019-05-14 | 2023-06-21 | Werewolf Therapeutics, Inc. | SEPARATION UNITS AND METHODS AND THEIR USE |
| WO2021097376A1 (en) | 2019-11-14 | 2021-05-20 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| US20210188934A1 (en) * | 2019-12-20 | 2021-06-24 | Regeneron Pharmaceuticals, Inc. | Novel il2 agonists and methods of use thereof |
| US20230235067A1 (en) * | 2020-06-02 | 2023-07-27 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | SSTR-2 Binding Chimeric Antigen Receptors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000068269A1 (en) * | 1999-05-10 | 2000-11-16 | The Salk Institute For Biological Studies | Constitutive chimeric receptors, and methods of use thereof |
| EP1290170A2 (en) * | 2000-06-16 | 2003-03-12 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
| US20090221477A1 (en) * | 2004-07-26 | 2009-09-03 | Asterion Limited | Linkers |
-
2009
- 2009-02-18 JP JP2010546400A patent/JP2011512134A/ja not_active Withdrawn
- 2009-02-18 US US12/867,747 patent/US20110172165A1/en not_active Abandoned
- 2009-02-18 WO PCT/GB2009/000437 patent/WO2009103965A1/en not_active Ceased
- 2009-02-18 EP EP09712897A patent/EP2288386A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011512134A5 (enExample) | ||
| DK2035447T3 (da) | Polypeptid | |
| HRP20170958T1 (hr) | Rekombinantni fsh uključujući alfa 2,3- i alfa 2,6- sialilaciju | |
| JP2011520976A5 (enExample) | ||
| JP2010143932A5 (enExample) | ||
| DK2378921T4 (da) | Sammensat element, multilagsplade og panelformet element til at danne det sammensatte element | |
| JP2011508438A5 (enExample) | ||
| PL2173381T3 (pl) | Polipeptydy o zmodyfikowanych funkcjach efektorowych wiążące się z receptorem Fc | |
| JP2011501007A5 (enExample) | ||
| JP2013523703A5 (enExample) | ||
| JP2011526809A5 (enExample) | ||
| CR10523A (es) | Cepa bg1 de thermoanaerobacter mathranii | |
| EP2558306A4 (en) | DIGITAL INJECTED DESIGN IN POWDER SURFACES | |
| PL2470518T3 (pl) | Pochodne estrów kwasu 2,5-furanodikarboksylowego i ich zastosowanie jako zmiękczacze | |
| ATE485941T1 (de) | Werkstoffverbund mit explosionsgeschweisstem zwischenstück | |
| ZA201105627B (en) | Improved anti-tnfr1 polypeptides,antibody variable domains & antagonists | |
| WO2006131564A3 (de) | Neue cystein-verarmte hydrophobinfusionsproteine, deren herstellung und verwendung | |
| SG172333A1 (en) | Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof | |
| EP2382311A4 (en) | POLYPEPTIDES WITH XYLANASE ACTIVITY | |
| WO2007115724A3 (en) | Method of increasing the in vivo recovery of therapeutic polypeptides | |
| IL209304A0 (en) | Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
| JP2007510403A5 (enExample) | ||
| WO2008005470A3 (en) | Polypeptides that bind membrane proteins | |
| JP2008517002A5 (enExample) | ||
| WO2009081170A3 (en) | Peptide fusion proteins |